Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

Danny Jonigk, Christopher Werlein, Till Acker, Martin Aepfelbacher, Kerstin Amann, Gustavo Baretton, Peter S. Barth, Rainer M. Bohle, Andreas Büttner, Reinhard Büttner, R. Dettmeyer, Philip Eichhorn, Sefer Elezkurtaj, Iréne Esposito, Katja Evert, Matthias Evert, Falko Fend, Nikolaus Gaßler, Stefan Gattenlöhner, Markus Glatzel, Heike Göbel, Elise Gradhand, Torsten Hansen, Arndt Hartmann, Axel Heinemann, Frank L. Heppner, Julia Hilsenbeck, David Horst, Jan C. Kamp, Gita Mall, Bruno Märkl, Benjamin Ondruschka, Jessica Pablik, Susanne Pfefferle, Alexander Quaas, Helena Radbruch, Christoph Röcken, Andreas Rosenwald, Wilfried Roth, Martina Rudelius, Peter Schirmacher, Julia Slotta‐Huspenina, Kevin Smith, Linna Sommer, Konrad Stock, Philipp Ströbel, Stephanie Strobl, Ulf Titze, Gregor Weirich, Joachim Weis, Martin Werner, Claudia Wickenhauser, Thorsten Wiech, Peter J. Wild, Tobias Welte, Saskia von Stillfried, Peter BoorArchiv 2022 · DOI

TL;DR

The COVID-19 pandemic has underscored the critical, and often overlooked, role of autopsies in understanding disease. This review synthesizes findings from over 1200 autopsies, revealing SARS-CoV-2's widespread presence and its characteristic impact on the vasculature, particularly in the lungs, leading to diffuse alveolar damage and microthrombosis. While respiratory findings are clear, extra-respiratory organ damage is often nonspecific, highlighting the need for continued autopsy-based research to unravel complex pathomechanisms and address long-term consequences like "long COVID."

What Problem Does This Paper Address?

The paper addresses the declining use of autopsies in modern medicine and the urgent need to re-establish their importance, particularly in the context of the COVID-19 pandemic. Before the pandemic, autopsy rates were decreasing, limiting our understanding of disease processes. The COVID-19 crisis, however, revealed the indispensable value of autopsies in directly analyzing affected organs, elucidating pathomechanisms, and providing crucial data for therapeutic strategies. The authors aim to consolidate and present the collective knowledge gained from a large-scale, nationwide autopsy initiative in Germany, highlighting both the successes and the remaining questions in understanding COVID-19's organ manifestations.

Methods

The paper is a comprehensive review that synthesizes findings from published literature and the experience of the DEFEAT PANDEMIcs network, comprising 27 German autopsy centers that performed over 1200 COVID-19 autopsies. The review discusses various autopsy techniques, including clinical, health authority-ordered, and forensic autopsies, as well as advanced methods like rapid and minimally invasive autopsies. It also covers the application of modern analytical techniques such as RT-qPCR, immunohistochemistry, electron microscopy, and advanced molecular methods like single-cell RNA sequencing and in situ hybridization for analyzing autopsy tissues. The focus is on how these methods contribute to understanding the pathophysiology of COVID-19.

Datasets

The paper does not present a specific dataset for training or evaluation in the traditional machine learning sense. Instead, it draws upon the collective data from the German Registry for COVID-19 Autopsies (DeRegCOVID) and the DEFEAT PANDEMIcs network, which encompasses over 1200 COVID-19 autopsies. This represents a large-scale, retrospective, multicenter data collection effort. The paper also references numerous publications that utilized autopsy data, forming the basis of their review.

Key Insights and Ideas

  • Autopsies are indispensable for understanding complex diseases: The pandemic has forcefully reminded the medical community that autopsies provide unique, direct insights into organ-level pathology that cannot be fully replicated by other diagnostic methods.
  • COVID-19 is an angiocentric disease: Beyond lung damage, the virus significantly affects the vasculature, leading to endothelial dysfunction, inflammation, and microthrombosis, which explains many of the severe clinical manifestations.
  • Extrapulmonary organ damage is often nonspecific: While the lungs show characteristic changes, damage in other organs is frequently subtle and difficult to attribute directly to viral infection versus secondary effects of critical illness.
  • The need for standardized autopsy protocols: The DEFEAT PANDEMIcs initiative highlights the value of organized, collaborative efforts to standardize data collection and biomaterial sharing for future pandemic preparedness.
  • Future research directions are clear: Autopsies are crucial for investigating emerging questions, including the mechanisms behind "long COVID," the impact of new viral variants, and the long-term consequences of the disease.

Key Results

The review highlights several key findings from the extensive autopsy data:

  • Widespread viral presence: SARS-CoV-2 was found in virtually all human organs and tissues, and in the majority of cells examined.
  • Pulmonary pathology: The characteristic findings include diffuse alveolar damage (DAD) with edema, hemorrhage, hyaline membranes, and pneumocyte damage. This is coupled with an angiocentric inflammatory process involving endothelial dysfunction, vascular inflammation, and microthrombosis.
  • Vascular impact: The extensive microangiopathy observed in COVID-19 lungs leads to hypoxia, intrapulmonary shunting, and increased pulmonary vascular resistance, which has informed antithrombotic treatment strategies.
  • Extra-respiratory organ findings: Pathological changes in organs like the kidney, liver, and nervous system are often nonspecific, making it challenging to distinguish direct viral effects from indirect consequences of severe illness.
  • Cardiovascular involvement: While cardiac injury markers are often elevated, direct viral myocarditis is rare, with endothelialitis and microvascular dysfunction being more prominent hypotheses.
  • Lymphatic system changes: Patients with severe COVID-19 often exhibit peripheral lymphopenia and alterations in lymph node architecture, reflecting a systemic inflammatory response.

Limitations and Future Work

The authors acknowledge several limitations and point towards future research:

  • Limitations:
    • Autopsy findings primarily reflect severe and late stages of the disease, potentially missing early or milder manifestations.
  • There is a risk of over-interpreting nonspecific findings in extra-respiratory organs.
  • A lack of comparable or matched control autopsy cohorts for many biomaterials and data points.
  • Future Work:
    • Continued interdisciplinary research integrating autopsy data with clinical studies, preclinical models, and humanized organoid systems is essential.
  • Investigating the mechanisms behind "long COVID" through autopsy and molecular methods to understand viral persistence, immune phenotypes, and autoimmune processes.
  • Focusing on emerging variants of concern and their specific organ tropism and pathological impact.
  • Establishing standardized protocols and building reference cohorts for future pandemics.
  • Strengthening national and international collaborative autopsy-based research initiatives.

Summary updated

Abstract

The use of autopsies in medicine has been declining. The COVID-19 pandemic has documented and rejuvenated the importance of autopsies as a tool of modern medicine. In this review, we discuss the various autopsy techniques, the applicability of modern analytical methods to understand the pathophysiology of COVID-19, the major pathological organ findings, limitations or current studies, and open questions. This article summarizes published literature and the consented experience of the nationwide network of clinical, neuro-, and forensic pathologists from 27 German autopsy centers with more than 1200 COVID-19 autopsies. The autopsy tissues revealed that SARS-CoV-2 can be found in virtually all human organs and tissues, and the majority of cells. Autopsies have revealed the organ and tissue tropism of SARS-CoV-2, and the morphological features of COVID-19. This is characterized by diffuse alveolar damage, combined with angiocentric disease, which in turn is characterized by endothelial dysfunction, vascular inflammation, (micro-) thrombosis, vasoconstriction, and intussusceptive angiogenesis. These findings explained the increased pulmonary resistance in COVID-19 and supported the recommendations for antithrombotic treatment in COVID-19. In contrast, in extra-respiratory organs, pathological changes are often nonspecific and unclear to which extent these changes are due to direct infection vs. indirect/secondary mechanisms of organ injury, or a combination thereof. Ongoing research using autopsies aims at answering questions on disease mechanisms, e.g., focusing on variants of concern, and future challenges, such as post-COVID conditions. Autopsies are an invaluable tool in medicine and national and international interdisciplinary collaborative autopsy-based research initiatives are essential.
BibTeX
@inproceedings{jonigk2022organ,
  author = {Danny Jonigk and Christopher Werlein and Till Acker and Martin Aepfelbacher and Kerstin Amann and Gustavo Baretton and Peter S. Barth and Rainer M. Bohle and Andreas Büttner and Reinhard Büttner and R. Dettmeyer and Philip Eichhorn and Sefer Elezkurtaj and Iréne Esposito and Katja Evert and Matthias Evert and Falko Fend and Nikolaus Gaßler and Stefan Gattenlöhner and Markus Glatzel and Heike Göbel and Elise Gradhand and Torsten Hansen and Arndt Hartmann and Axel Heinemann and Frank L. Heppner and Julia Hilsenbeck and David Horst and Jan C. Kamp and Gita Mall and Bruno Märkl and Benjamin Ondruschka and Jessica Pablik and Susanne Pfefferle and Alexander Quaas and Helena Radbruch and Christoph Röcken and Andreas Rosenwald and Wilfried Roth and Martina Rudelius and Peter Schirmacher and Julia Slotta‐Huspenina and Kevin Smith and Linna Sommer and Konrad Stock and Philipp Ströbel and Stephanie Strobl and Ulf Titze and Gregor Weirich and Joachim Weis and Martin Werner and Claudia Wickenhauser and Thorsten Wiech and Peter J. Wild and Tobias Welte and Saskia von Stillfried and Peter Boor},
  title = {{Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?}},
  booktitle = {Archiv},
  year = {2022},
  doi = {10.1007/s00428-022-03319-2},
}
Figure